CD19 and acute lymphoblastic leukemia: The bispecific CAR T cells cleared pediatric ALL with a mixed CD19+CD20+/CD20- phenotype from the blood and bone marrow of transplanted mice, while anti-CD20 CAR T cells left CD20- leukemic cells behind without curing the disease.